Can uncertainty boost the reliability of AI-based diagnostic methods in digital pathology?

Deep learning (DL) has shown great potential in digital pathology applications. The robustness of a diagnostic DL-based solution is essential for safe clinical deployment. In this work we evaluate if adding uncertainty estimates for DL predictions in digital pathology could result in increased value for the clinical applications, by boosting the general predictive performance or by detecting mispredictions. We compare the effectiveness of model-integrated methods (MC dropout and Deep ensembles) with a model-agnostic approach (Test time augmentation, TTA). Moreover, four uncertainty metrics are compared. Our experiments focus on two domain shift scenarios: a shift to a different medical center and to an underrepresented subtype of cancer. Our results show that uncertainty estimates can add some reliability and reduce sensitivity to classification threshold selection. While advanced metrics and deep ensembles perform best in our comparison, the added value over simpler metrics and TTA is small. Importantly, the benefit of all evaluated uncertainty estimation methods is diminished by domain shift.

Unsupervised anomaly detection in digital pathology using GANs

Machine learning (ML) algorithms are optimized for the distribution represented by the training data. For outlier data, they often deliver predictions with equal confidence, even though these should not be trusted. In order to deploy ML-based digital pathology solutions in clinical practice, effective methods for detecting anomalous data are crucial to avoid incorrect decisions in the outlier scenario. We propose a new unsupervised learning approach for anomaly detection in histopathology data based on generative adversarial networks (GANs). Compared to the existing GAN-based methods that have been used in medical imaging, the proposed approach improves significantly on performance for pathology data. Our results indicate that histopathology imagery is substantially more complex than the data targeted by the previous methods. This complexity requires not only a more advanced GAN architecture but also an appropriate anomaly metric to capture the quality of the reconstructed images.

Survey of XAI in digital pathology

Artificial intelligence (AI) has shown great promise for diagnostic imaging assessments. However, the application of AI to support medical diagnostics in clinical routine comes with many challenges. The algorithms should have high prediction accuracy but also be transparent, understandable and reliable. Thus, explainable artificial intelligence (XAI) is highly relevant for this domain. We present a survey on XAI within digital pathology, a medical imaging sub-discipline with particular characteristics and needs. The review includes several contributions. Firstly, we give a thorough overview of current XAI techniques of potential relevance for deep learning methods in pathology imaging, and categorise them from three different aspects. In doing so, we incorporate uncertainty estimation methods as an integral part of the XAI landscape. We also connect the technical methods to the specific prerequisites in digital pathology and present findings to guide future research efforts. The survey is intended for both technical researchers and medical professionals, one of the objectives being to establish a common ground for cross-disciplinary discussions.